Catalyst Wire Dossier Catalyst Wire Dossier

XIENCE V Endoprothesis

Everolimus-eluting stent · Abbott Vascular
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XIENCE V Endoprothesis, covering 2012-04-19 to 2012-04-19. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of a XIENCE V® Endoprothesis Used for Coronary Angioplasty, for LPPR (List of Reimbursable Products and Services) Indications in Patients Monitored for 2 Years in France

See pricing